Related references
Note: Only part of the references are listed.Prospective Seroepidemiologic Study of Human Papillomavirus and Other Risk Factors in Cervical Cancer
Lisen Arnheim Dahlstrom et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
Nubia Munoz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
Joakim Dillner et al.
BRITISH MEDICAL JOURNAL (2010)
Population dynamics of serologically identified coinfections with human papillomavirus types 11, 16, 18 and 31 in fertile-aged Finnish women
Marjo Kaasila et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia-Grade 2
Philip E. Castle et al.
OBSTETRICS AND GYNECOLOGY (2009)
Introducing human papillomavirus vaccines - questions remain
Jorma Paavonen et al.
ANNALS OF MEDICINE (2008)
CIN2 is a much less reproducible and less valid diagnosis than CIN3: Results from a histological review of population-based cervical samples
Joseph D. Carreon et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2007)
Geographic distribution of cervical cancer-associated human leucocyte antigens and cervical cancer incidence in Finland
Felipe A. Castro et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2007)
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update
Jennifer S. Smith et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women:: an interim analysis of a phase III double-blind, randomised controlled trial
Jorma Paavonen et al.
LANCET (2007)
Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990s
Matti Lehtinen et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries
Matti Lehtinen et al.
VACCINE (2006)
Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing
Matti Lehtinen et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2006)
Population-based enrolment of adolescents in a long-term follow-up trial of human papillomavirus vaccine efficacy
M Lehtinen et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2006)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A prospective study of the relationship between prediagnostic Human Papillomavrus seropositivity and HPV DNA in subsequent cervical carcinomas
E Sigstad et al.
BRITISH JOURNAL OF CANCER (2002)
The causal relation between human papillomavirus and cervical cancer
FX Bosch et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Share Paper
